Exponent Inc. Common Stock (EXPO)
Stock · NASDAQ · Consumer Discretionary
$71.85as of 10/16/2026
Price chart
Active signals
EXPO Signal Track Record
How signals performed across all stocks →What EXPO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 34 | +1.4% | 56% | September 15, 2026 |
| Bollinger Band Breakdown | 23 | -0.8% | 48% | September 24, 2026 |
| 200-Day Moving Average TouchActive now | 20 | -3.6% | 35% | September 11, 2026 |
| Bollinger Band Breakout | 19 | +1.1% | 58% | July 28, 2026 |
| Any 20-session window (baseline) | -0.3% | 48% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About EXPO
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrica…
- Sector
- Consumer Discretionary
- Industry
- Professional Services
- Employees
- 1,012
- Website
- www.exponent.com/
Fundamentals
- 1-day range
- $70.05$71.83
- Market cap
- $3.21B
- P/E (trailing)
- 30.85
- P/E (forward)
- 26.20
- EPS (trailing)
- $2.14
- Dividend yield
- 1.34%
- Beta
- 0.73
- Avg. volume
- 517.3K
- Ex-dividend date
- September 4, 2026
- Dividend pay date
- September 18, 2026
How Exponent Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 27, 2026 · via SEC EDGAR / Finnhub
Forecasts
3 analyst ratings
Exponent Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- EXPOExponent Inc. Common Stock$71.85▼ 0.59%Market cap $3.21BP/E 30.85$51.91$81.95
- MANManpowerGroup Common Stock$41.49▼ 5.14%Market cap $2.57BP/E 19.65$25.15$63.88
- HURNHuron Consulting Group Inc. Common Stock$174.86▼ 0.35%Market cap $2.39BP/E 24.12$84.88$186.78
- RHIRobert Half Inc. Common Stock$33.31▼ 3.14%Market cap $4.16BP/E 30.36$21.83$46.7
- FCNFTI Consulting Inc. Common Stock$148.53▲ 1.57%Market cap $4.17BP/E 16.06$129.12$189.3
- NSPInsperity Inc. Common Stock$51.38▲ 1.14%Market cap $1.96BP/E —$18.57$55.9
- ASTHAstrana Health Inc. Common Stock$36.81▼ 3.21%Market cap $1.90BP/E 45.53$18.08$51.6
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| EXPO Exponent Inc. Common Stock | $3.21B | 30.85 | $71.85 | ▼ 0.59% | $51.91$81.95 |
| MAN ManpowerGroup Common Stock | $2.57B | 19.65 | $41.49 | ▼ 5.14% | $25.15$63.88 |
| HURN Huron Consulting Group Inc. Common Stock | $2.39B | 24.12 | $174.86 | ▼ 0.35% | $84.88$186.78 |
| RHI Robert Half Inc. Common Stock | $4.16B | 30.36 | $33.31 | ▼ 3.14% | $21.83$46.7 |
| FCN FTI Consulting Inc. Common Stock | $4.17B | 16.06 | $148.53 | ▲ 1.57% | $129.12$189.3 |
| NSP Insperity Inc. Common Stock | $1.96B | — | $51.38 | ▲ 1.14% | $18.57$55.9 |
| ASTH Astrana Health Inc. Common Stock | $1.90B | 45.53 | $36.81 | ▼ 3.21% | $18.08$51.6 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Exponent (EXPO) Stock Looks Reasonable Against Its Cash Flow ValueYahoo · 10/10/2026
- Exponent to Announce Third Quarter of Fiscal Year 2026 Results and Host Quarterly Conference Call on October 29, 2026Yahoo · 10/8/2026
- Are Business Services Stocks Lagging RCM Technologies (RCMT) This Year?Yahoo · 10/2/2026
- Andersen Group shares are trading higher after UBS maintained its Buy rating on the stock and raised its price target from $32 to $34.Benzinga · 10/1/2026
- Exponent Hosts Investor DayYahoo · 9/30/2026
- Exponent: The Recovery Is Real, But Capacity Still Sets The Speed LimitSeekingAlpha · 9/27/2026
- Xeinadin appoints John Dwyer as new chairmanYahoo · 9/18/2026
- Dividend Champion, Contender, And Challenger Highlights: Week September 13SeekingAlpha · 9/11/2026
Insider Activity
Insider Actions →- Souri Shukri Jeries · September 18, 2026 · Buy184 @ $68.45
- Catherine Corrigan · August 17, 2026 · Option Exercise2.4K @ $29.05
- Catherine Corrigan · August 17, 2026 · Sale1.7K @ $66.28
- Catherine Corrigan · July 28, 2026 · Option Exercise12.7K @ $37.45
- Catherine Corrigan · July 15, 2026 · Option Exercise2.4K @ $29.05
- Catherine Corrigan · July 15, 2026 · Sale1.7K @ $62.78
- Catherine Corrigan · June 15, 2026 · Option Exercise2.4K @ $29.05
- Catherine Corrigan · June 15, 2026 · Option Exercise3.2K @ $25.41
- Catherine Corrigan · June 15, 2026 · Sale1.8K @ $57.13
- Catherine Corrigan · June 15, 2026 · Sale2.3K @ $57.13
- George H. Brown · June 4, 2026 · Grant2.9K
- Carol Lindstrom · June 4, 2026 · Grant2.9K
- Debra Zumwalt · June 4, 2026 · Grant2.9K
- Karen A. Richardson · June 4, 2026 · Grant2.9K
- George H. Brown · June 3, 2026 · Option Exercise2.0K
Institutional Ownership
March 31, 2026
- Total shares held
- 42.95M
- Total value held
- $2.76B
- Institutional holders
- 345
- Unknown6.07M
- Unknown3.89M
- Unknown2.21M
- Unknown1.91M
- Unknown1.89M
- Unknown1.80M
- Unknown1.65M
- Unknown1.14M
- Unknown1.10M
- Unknown1.07M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Exponent stock viewed as reasonable versus cash flow value
A recent Yahoo analysis notes that Exponent’s share price appears reasonable when compared with its cash‑flow generation. The view aligns with the company’s current valuation metrics, including a trailing P/E of about 30.6 and a dividend yield of 1.34%. Analysts’ average target price of $84 sits within the recent 52‑week range, suggesting the market’s expectations are consistent with the cash‑flow assessment.
Exponent stock viewed as reasonable versus cash flow value. A recent Yahoo analysis notes that Exponent’s share price appears reasonable when compared with its cash‑flow generation. The view aligns with the company’s current valuation metrics, including a trailing P/E of about 30.6 and a dividend yield of 1.34%. Analysts’ average target price of $84 sits within the recent 52‑week range, suggesting the market’s expectations are consistent with the cash‑flow assessment.